An open-label, multicenter study to evaluate the safe and effective use of the single-use autoinjector with an Avonex(® )prefilled syringe in multiple sclerosis subjects

BACKGROUND: The ability to self-inject in patients with multiple sclerosis (MS) has been associated with a reduced risk of missed injections and drug discontinuation, and a beneficial effect on patients' independence. However, injection anxiety, needle phobia and disease-related disability are...

Descripción completa

Detalles Bibliográficos
Autores principales: Phillips, J Theodore, Fox, Edward, Grainger, William, Tuccillo, Dianne, Liu, Shifang, Deykin, Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213083/
https://www.ncbi.nlm.nih.gov/pubmed/21999176
http://dx.doi.org/10.1186/1471-2377-11-126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213083/
https://www.ncbi.nlm.nih.gov/pubmed/21999176
http://dx.doi.org/10.1186/1471-2377-11-126

Ejemplares similares